Activation of \u3cem\u3eTomato Bushy Stunt Virus\u3c/em\u3e RNA-Dependent RNA Polymerase by Cellular Heat Shock Protein 70 Is Enhanced by Phospholipids \u3cem\u3eIn Vitro\u3c/em\u3e by Pogany, Judit & Nagy, Peter D.
University of Kentucky
UKnowledge
Plant Pathology Faculty Publications Plant Pathology
5-2015
Activation of Tomato Bushy Stunt Virus RNA-
Dependent RNA Polymerase by Cellular Heat
Shock Protein 70 Is Enhanced by Phospholipids In
Vitro
Judit Pogany
University of Kentucky, jpoga2@uky.edu
Peter D. Nagy
University of Kentucky, pdnagy2@uky.edu
Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/plantpath_facpub
Part of the Plant Pathology Commons
This Article is brought to you for free and open access by the Plant Pathology at UKnowledge. It has been accepted for inclusion in Plant Pathology
Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.
Repository Citation
Pogany, Judit and Nagy, Peter D., "Activation of Tomato Bushy Stunt Virus RNA-Dependent RNA Polymerase by Cellular Heat Shock
Protein 70 Is Enhanced by Phospholipids In Vitro" (2015). Plant Pathology Faculty Publications. 37.
https://uknowledge.uky.edu/plantpath_facpub/37
Activation of Tomato Bushy Stunt Virus RNA-Dependent RNA Polymerase by Cellular Heat Shock Protein 70 Is
Enhanced by Phospholipids In Vitro
Notes/Citation Information
Published in Journal of Virology, v. 89, no. 10, p. 5714-5723.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
The copyright holders have granted the permission for posting the article here.
Digital Object Identifier (DOI)
http://dx.doi.org/10.1128/JVI.03711-14
This article is available at UKnowledge: https://uknowledge.uky.edu/plantpath_facpub/37
Activation of Tomato Bushy Stunt Virus RNA-Dependent RNA
Polymerase by Cellular Heat Shock Protein 70 Is Enhanced by
Phospholipids In Vitro
Judit Pogany, Peter D. Nagy
Department of Plant Pathology, University of Kentucky, Lexington, Kentucky, USA
ABSTRACT
Similar to other positive-strand RNA viruses, tombusviruses are replicated by the membrane-bound viral replicase complex
(VRC). The VRC consists of the p92 virus-coded RNA-dependent RNA polymerase (RdRp), the viral p33 RNA chaperone, and
several co-opted host proteins. In order to become a functional RdRp after its translation, the p92 replication protein should be
incorporated into the VRC, followed by its activation. We have previously shown in a cell-free yeast extract-based assay that the
activation of the Tomato bushy stunt virus (TBSV) RdRp requires a soluble host factor(s). In this article, we identify the cellular
heat shock protein 70 (Hsp70) as the co-opted host factor required for the activation of an N-terminally truncated recombinant
TBSV RdRp. In addition, small-molecule-based blocking of Hsp70 function inhibits RNA synthesis by the tombusvirus RdRp in
vitro. Furthermore, we show that neutral phospholipids, namely, phosphatidylethanolamine (PE) and phosphatidylcholine
(PC), enhance RdRp activation in vitro. In contrast, phosphatidylglycerol (PG) shows a strong and dominant inhibitory effect on
in vitro RdRp activation. We also demonstrate that PE and PC stimulate RdRp-viral plus-strand RNA [()RNA] interaction,
while PG inhibits the binding of the viral RNA to the RdRp. Based on the stimulatory versus inhibitory roles of various phospho-
lipids in tombusvirus RdRp activation, we propose that the lipid composition of targeted subcellular membranes might be uti-
lized by tombusviruses to regulate new VRC assembly during the course of infection.
IMPORTANCE
The virus-coded RNA-dependent RNA polymerase (RdRp), which is responsible for synthesizing the viral RNA progeny in in-
fected cells of several positive-strand RNA viruses, is initially inactive. This strategy is likely to avoid viral RNA synthesis in the
cytosol that would rapidly lead to induction of RNA-triggered cellular antiviral responses. During the assembly of the mem-
brane-bound replicase complex, the viral RdRp becomes activated through an incompletely understood process that makes the
RdRp capable of RNA synthesis. By using TBSV RdRp, we show that the co-opted cellular Hsp70 chaperone and neutral phos-
pholipids facilitate RdRp activation in vitro. In contrast, phosphatidylglycerol (PG) has a dominant inhibitory effect on in vitro
RdRp activation and RdRp-viral RNA interaction, suggesting that the membranous microdomain surrounding the RdRp greatly
affects its ability for RNA synthesis. Thus, the activation of the viral RdRp likely depends onmultiple host components in in-
fected cells.
Replication of plus-strand RNA [()RNA] viruses requires theassembly of the viral replicase on subcellular membrane sur-
faces. The viral replicase complex (VRC) consists of virus-coded
RNA-dependent RNA polymerase (RdRp), viral auxiliary replica-
tion proteins, and a number of co-opted host proteins (1–7). In-
terestingly, the viral RdRp is assumed to be inactive in the cytosol
to prevent the formation of a viral double-stranded RNA (dsRNA)
intermediate that could trigger efficient gene silencing and RNA-
induced innate immunity (8–10). Therefore, the VRC assembly,
including the activation of the viral RdRp, could be a critical reg-
ulatory step during the infection cycle.
The tombusvirus VRCs are housed in membranous spherule
structures, which are membrane invaginations into peroxisomes
or mitochondria in the cases of Tomato bushy stunt virus (TBSV)
and Carnation Italian ringspot virus (CIRV), respectively (11–15).
The tombusvirus VRCs contain the virus-coded p92 RdRp and
p33 RNA chaperone and the dsRNA intermediate, as well as
co-opted cellular proteins, such as the heat shock protein 70
(Hsp70) molecular chaperone (coded for by yeast [Saccharomyces
cerevisiae] SSA1/2), glyceraldehyde-3-phosphate dehydrogenase
(GAPDH [coded for by TDH2/3 in yeast]), Cdc34p E2 ubiquitin-
conjugating enzyme, eukaryotic translation elongation factor 1A
(eEF1A), eEF1B, the Vps4p ESCRT (endosomal sorting complex
required for transport) protein, and DDX3-like Ded1p and
eIF4AIII-like RH2 DEAD box helicases (16–30). Hsp70, eEF1A,
Cdc34p, and ESCRT proteins are involved in the assembly of the
tombusviral VRC, while other subverted RNA-binding proteins
(eEF1A, eEF1B, GAPDH, Ded1p, and RH2) facilitate viral RNA
synthesis (1, 3, 18, 31). Tombusvirus replication also depends on
lipids, such as sterols and phospholipids, and oxysterol-binding
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proteins (ORPs) that help the formation of the sterol- and phos-
pholipid-rich microenvironment needed for VRC formation
(32–34).
Similar to TBSV, several ()RNA viruses also have RdRps that
need activation before RNA synthesis initiates. The list includes
Cucumber necrosis virus (CNV) p92, Brome mosaic virus (BMV)
2apol, P2 of Alfalfa mosaic virus, Tomato mosaic virus (ToMV)
180K, the Hepatitis C virus (HCV) NS5B RdRp proteins, and no-
davirus protein A (35–39). After activation, many viral RdRps
could be purified and their activities characterized in template-
dependent in vitro assays (40).
To dissect the roles of viral and host factors during the TBSV
RdRp activation step, we have previously developed a simplified
system based on N-terminally truncated TBSV p92pol RdRp that
requires fewer components than the complete p92pol/p33 repli-
case for activation of the RNA synthesis function (41). Unlike the
full-length TBSV p92pol, the N-terminally truncated TBSV p92-
167N RdRp does not require the p33 replication cofactor or
cellular membranes to produce RNA products on the added viral
()RNA templates in vitro (18, 41). The activation of TBSV p92-
167N RdRp still needs a soluble host factor(s) and a cis-acting
viral ()RNA element. Accordingly, the Escherichia coli-ex-
pressed and purified TBSV p92-167N RdRp shows little RdRp
activity in the absence of the soluble fraction of yeast cell-free
extract (CFE), indicating that a subverted host factor(s) is critical
for RdRp activation (41).
In this work, we show that the purified cellular Ssa1p Hsp70
chaperone is able to activate the RdRp function of p92-167N in
vitro. In addition, phospholipids, such as phosphatidylethano-
lamine (PE) and phosphatidylcholine (PC), could further en-
hance the RdRp activity of TBSV p92-167N in vitro. PE and PC
also promote the RNA binding capability of TBSV p92-167N
with the viral ()RNA template. Interestingly, other phospholip-
ids, such as phosphatidylglycerol (PG), repress the activation of
TBSV p92-167N and strongly inhibit RdRp-RNA interactions.
Altogether, the presented data indicate that the co-opted cellular
Hsp70 and phospholipids are important factors regulating viral
functions, including the RdRp activation and replication protein-
viral RNA interactions, which are critical for VRC assembly in
infected cells.
MATERIALS AND METHODS
Affinity purification of recombinant tombusvirus replicase protein
from yeast for mass spectrometry analysis. FLAG-tagged p92-167N
was expressed from the copper-inducible CUP1 promoter at 29°C. Fol-
lowing protein induction, yeast proteins were cross-linked using formal-
dehyde according to reference 42. Yeast cells were broken in breaking
buffer (30 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM EDTA) containing
-mercaptoethanol and yeast protease inhibitor cocktail, using a Fast
Prep machine. Low-speed centrifugation was used at 500 g for 5 min to
remove cellular debris. After centrifugation, the NaCl concentration of
the supernatant was adjusted to 0.5 M, Triton X-100 was added to a 1%
final concentration, and the mixture was centrifuged at 43,000 g for 30
min. The supernatant was loaded on an equilibrated FLAG-affinity col-
umn. The column was washed 3 times with wash buffer (breaking buffer
containing 0.5 M NaCl and 1% Triton). The bound proteins were eluted
with the FLAG-tagged peptide in the wash buffer containing 0.5% Triton.
To reverse cross-linking, the purified protein preparations were boiled for
30 min in SDS-PAGE loading dye. The protein sample was run into the
separating gel of an SDS-PAGE gel with a very short run. A narrow band
containing the proteins was excised from the gel and submitted for mass
spectrometry analysis.
Preparation of phospholipids. The phospholipids used in these ex-
periments included 18:1 PE (1,2-dioleoyl-sn-glycero-3-phosphoetha-
nolamine), 18:1 PC (1,2-dioleoyl-sn-glycero-3-phosphocholine), 18:1
PS (1,2-dioleoyl-sn-glycero-3-phospho-L-serine), 18:1 PG [1,2-dio-
leoyl-sn-glycero-3-phospho-(1=-rac-glycerol)], 18:1 CA (1=,3=-bis
[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol), 18:1 lysoPE (1-ole-
oyl-2-hydroxy-sn-glycero-3-phosphoethanolamine), 18:1 lysoPC (1-
oleoyl-2-hydroxy-sn-glycero-3-phosphocholine), L--phosphatidylinositol-
3-phosphate (PI3P), and cholesterol and were obtained from Avanti Polar
lipids and stored in chloroform.
Lipids were added into glass vials and subsequently dried under
vacuum for 2 to 3 h. Dimethyl sulfoxide (DMSO) was added to each
vial to make up the lipid concentration to 700 M, followed by exten-
sive vortexing. Two microliters of each lipid was used in a 20-l in vitro
assay, unless noted otherwise in the figure legend. The final DMSO
concentration was kept at 10% in all in vitro reactions except when
noted otherwise.
Expression and purification of recombinant tombusvirus replicase
proteins from E. coli. The maltose-binding protein (MBP)-tagged TBSV
p92-167N replicase protein was expressed in E. coli and purified accord-
ing to reference 41. MBP-p33C is an N-terminally truncated TBSV p33
protein expressed as an MBP fusion protein (43). p92-167N RdRp is an
N-terminally truncated TBSV-p92 protein (41).
Preparation of RNA templates for in vitro RdRp and replicase as-
says. We produced the following set of RNA templates: DI-72 minus-
strand RNA [(	)RNA] (44) and DI-mini [()RNA] (35). The T7-based
in vitro transcription reaction was done after the PCR amplification and
purification of PCR products (45).
EMSA. Electrophoretic mobility shift assay (EMSA) experiments were
done according to reference 43. The 32P-labeled RII()SL hairpin se-
quence was used for the EMSAs with MBP-p33C (43). DI-mini ()RNA
was used for the gel shift experiments with p92-167N RdRp. For the
latter EMSAs, the soluble fraction of yeast CFE was also added as described
previously (41).
In vitroRdRp assay.Recombinant affinity-purified MBP-p92-167N
RdRp was incubated with the yeast soluble fraction (2 l) in a buffer
containing 50 mM HEPES-KOH (pH 7.4), 50 mM potassium acetate, 5
mM magnesium acetate, 0.2 M sorbitol, 0.4l actinomycin D (5 mg/ml),
2 l of 150 mM creatine phosphate, 2 l of 10 mM ATP, CTP, and GTP
and 0.25 mM UTP, 0.1l of [32P]UTP, 0.2l of 10 mg/ml creatine kinase,
0.2 l of RNase inhibitor, 0.2 l of 1 M dithiothreitol, and 0.5 g RNA
transcript in a 20-l reaction mixture.
The reaction mixture was incubated at 25°C for 3 h, followed by ter-
mination by the addition of 110l stop buffer (1% sodium dodecyl sulfate
[SDS], 0.05 M EDTA [pH 8.0]). Then phenol-chloroform extraction was
performed, followed by isopropanol-ammonium acetate precipitation,
and a washing step with 70% ethanol as described earlier (41).
In vitro RdRp activation assay. Yeast cell-free extract (CFE) was pre-
pared according to reference 18. The CFE was centrifuged at 4°C for 20
min at 42,000  g to obtain the soluble (supernatant) CFE fraction.
FLAG-tagged yeast Ssa1p (Hsp70) was overexpressed in yeast and purified
using an anti-FLAG column according to reference 18. The HSP70 inhib-
itor (MKT-077) was dissolved in DMSO (46) and added to the in vitro
reaction mixture in 50 and 100 M final concentrations. DMSO was
added to the control reaction mixtures. The RdRp activation assay was
conducted as the standard in vitro RdRp assay, except that the soluble
fraction was replaced with the FLAG-tagged purified Ssa1p Hsp70 and 2
l phospholipids dissolved in DMSO. As a control, we added 2l DMSO
to the reaction mixture lacking phospholipids.
Replication assay based on affinity-purified replicase. FLAG-tagged
CNV replicase complex was purified from yeast expressing FLAG-
CNV92, FLAG-CNV33, and DI-72 replicon RNA as described previously
(28, 35, 36).
Hsp70 Activates the TBSV RdRp
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RESULTS
Mass spectrometry-based identification of yeast proteins copu-
rified with a truncated p92pol replication protein. The recombi-
nant TBSV p92-167N (Fig. 1A), which is inactive in the RdRp
buffer, is activated in vitro by the addition of the soluble fraction of
yeast CFE, suggesting that this fraction contains a cellular pro-
tein(s) required for RdRp activation (41). To identify the putative
soluble factor(s) involved in RdRp activation in the yeast CFE, we
expressed FLAG-tagged p92-167N RdRp in yeast, followed by
FLAG affinity purification of the RdRp protein. We then per-
formed mass spectrometry analysis of the copurified yeast pro-
teins in the affinity-purified p92-167N preparation, which re-
vealed the presence of at least 13 yeast proteins (Table 1).
Altogether, we have identified five yeast proteins that have previ-
ously been shown to be part of the tombusvirus VRC, including
Ssa1p and Ssa2p Hsp70 chaperones, Tdh3 (GAPDH), Tef1p
(eEF1A), and Pdc1p (19, 25, 28). An additional two yeast proteins
have been identified in previous high-throughput screens,
namely, Cdc19p and Pgk1p (47, 48). The remaining 6 yeast pro-
teins have not been identified in previous screens (Table 1). Since
the copurified yeast proteins included five heat shock protein mo-
lecular chaperones, it is possible that one or more of these cellular
chaperones could participate in the activation of the tombusvirus
RdRp during infections. We have decided to further study the role
of the cytosolic Hsp70 (the SSA1-4 subfamily in yeast) based on its
functions in tombusvirus VRC assembly and localization of p33
and p92pol replication proteins in subcellular membranes (16–
18). Ssa1/2 are permanent residents of the tombusvirus VRCs,
FIG 1 In vitro activation of the RdRp function of the N-terminally truncated p92pol replication protein depends on cellular Hsp70 chaperone. (A) Schematic
representation of the known domains in the p92-167N RdRp. The missing 167-amino-acid (aa) N-terminal sequence is indicated by a dotted line. The
full-length TBSV p33 and p92 replication proteins are shown at the top. The N-terminal segment in the TBSV p92pol contains the same sequence as p33 due to
the overlapping expression strategy of TBSV genome, while the C-terminal region of p92pol carries the RdRp domain and two RNA-binding sequences. The
various domains in the shared sequences are termed as follows: mPTS, peroxisomal membrane targeting sequences; ub, monoubiquitinylation sites; TMD,
transmembrane domains; late domain, sequence recognized by the ESCRT factors; P, phosphorylation sites; RPR, arginine-proline-rich RNA-binding domain,
required for selective recognition of RII()-SL sequence in the viral ()RNA. S1 and S2 are subdomains of the p33-p33/p92 interaction domain. (B) Based on
previous work, the activated recombinant p92-167N RdRp protein produces a 3=-terminal extension (3=-TEX) product and terminates prematurely at the
hairpin structure, as shown. Schematic representation of DI-mini ()RNA template with the known cis-acting p33RE RNA element [RII()-SL carrying the
critical C·C mismatch required for template recognition by the TBSV replication proteins] and the short RIV(), which harbors cis-elements for minus-strand
synthesis (but missing the ss4 region). (C) Scheme of the in vitro RNA synthesis assay with DI-mini ()RNA and p92-167N RdRp protein. (Right panel)
Denaturing PAGE analysis of the 32P-labeled RNA products obtained in an in vitro assay with recombinant p92-167N RdRp. The samples contained or lacked
affinity-purified Ssa1p Hsp70 protein (13 pmol) with or without DMSO. The 3=-TEX product is pointed at with an open arrowhead. The amounts of 3=TEX
products were estimated using the Imagequant software. (D) Scheme of the in vitro RNA synthesis assay in the presence of an allosteric Hsp70 inhibitor
(MKT-077). The assay also contained DI-mini ()RNA and p92-167N RdRp protein in the presence of only the soluble fraction of CFE (used in the same
amount in each sample). See further details in the legend for panel C. DMSO, which was used as a solvent for MKT-077, was used as a control. Each experiment
was repeated two or three times.
Pogany and Nagy
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but they do not seem to affect minus- or plus-strand synthesis (16,
19, 30).
Ssa1pHsp70 activates the RdRp function of the TBSV p92pol
replication protein in vitro. We first tested a purified yeast Ssa1p
Hsp70 preparation in combination with p92-167N and a tem-
plate RNA (Fig. 1B) in an in vitro RNA synthesis assay (Fig. 1C).
This assay demonstrated that the purified Ssa1p was able to acti-
vate the RdRp function of TBSV p92-167N in the presence of
DMSO (Fig. 1C, lanes 7 to 8). As expected, TBSV p92-167N did
not show RdRp activity in the absence of Ssa1p and DMSO in the
RdRp buffer (Fig. 1C, lanes 1 to 2). As we have demonstrated
before (41) and schematically shown in Fig. 1B, the TBSV p92-
167N synthesized 32P-labeled 3=-terminal extension (3=-TEX)
product using the DI-mini template (while no de novo-initiated
products were detected [data not shown]).
To confirm that indeed Hsp70 is the soluble cellular factor in
the yeast CFE required for activation of p92-167N, we added a
specific Hsp70 inhibitor, called MKT-077 (46), to the RdRp acti-
vation assay containing p92-167N, the soluble fraction of yeast
CFE, and DI-mini template (Fig. 1D). The Hsp70 inhibitor
strongly inhibited the activity of p92-167N in vitro (Fig. 1D,
compare lanes 2 to 5 with 6 to 7). Altogether, these data have
established an essential role for the cellular Hsp70 in the in vitro
activation of the TBSV RdRp function.
Neutral PE and PCphospholipids enhance the activity of the
TBSV RdRp in vitro. Although Ssa1p was able to activate the
RdRp function of TBSV p92-167N, the observed level of RNA
synthesis is only
20 to 30% of that measured with the whole CFE
(data not shown), suggesting that other factors will also contribute
to enhancement of TBSV RdRp activity. To this end, we have
tested phospholipids because TBSV replicates in a membranous
environment (spherule-like structures in the peroxisomal mem-
brane), and depletion of phospholipids in cellular membranes has
adverse effects on TBSV replication (14, 26, 33, 49).
We have decided to study the effects of the most abundant
phospholipids in cells, such as the neutral phosphatidylethano-
lamine (PE) and phosphatidylcholine (PC), phosphatidylinositol-
3-phosphate (PI3P), and the negatively charged phosphatidyl-
glycerol (PG) and cardiolipin (CA or CL). While these
phospholipids alone did not activate the RdRp function of p92-
167N (not shown), we observed 
2.5-fold stimulation of
RNA synthesis by p92-167N in the presence of PE and PC in
combination with Ssa1p Hsp70 and DMSO (Fig. 2A, lanes 3 to
6 versus 11 and 12). On the other hand, PI3P did not enhance
the activity of p92-167N, while PG and the total lipids from E.
coli inhibited the RdRp activity (Fig. 2A). In contrast, these phos-
pholipids affected the in vitro activity of the purified tombusvirus
replicase, which has been assembled and activated in yeast prior to
isolation, by only 15 to 30% (Fig. 2B). This effect on RdRp activity
is negligible in comparison to the effects of these phospholipids on
RdRp activation. Altogether, our results demonstrate that neutral
phospholipids are not essential but stimulate the activation of the
RdRp in vitro.
The acidic PGphospholipid is a potent inhibitor of theTBSV
RdRp activity in vitro. The above-described experiments have
indicated that the addition of acidic PG inhibited the RdRp acti-
vation (Fig. 2A). To characterize the inhibitory role of PG on the
RdRp activation, we used increasing concentrations of PG in
the RdRp activation assay. Interestingly, 14 M PG completely
blocked the RdRp activity, while 3 M PG reduced the activity to

40% (Fig. 3A, lanes 4 to 7). Thus, PG seems to act as a potent
inhibitor of RdRp activation.
TABLE 1 Yeast proteins copurified with TBSV p92-167N
Protein
No. of
peptides Function
Ssa1a 18 Member of HSP70 family, cytosolic ATPase involved in
protein folding
Ssa2a 17 Member of HSP70 family, 98% identical to paralog Ssa1p
Eno2 4 Enolase II, phosphopyruvate hydratase
Tdh3a 5 GAPDH
Ssb1 4 Member of HSP70 family, cytoplasmic ATPase,
ribosome-associated chaperone
Hsc82 7 Cytoplasmic chaperone of Hsp90 family
Tef1a 3 Translational elongation factor EF-1 alpha
Cdc19b 5 Pyruvate kinase
Eft1 2 Elongation factor 2 (EF-2), catalyzes ribosomal
translocation during protein synthesis
Pgk1b 1 3-Phosphoglycerate kinase, ATP synthesis
Hsp104 1 Disaggregase, heat shock protein
Leu1 1 Isopropylmalate isomerase, catalyzes second step in
leucine biosynthesis pathway
Pdc1a 1 Major of 3 pyruvate decarboxylase isozymes
a Present in the tombusvirus VRC.
b Identified as a host factor for TBSV previously.
FIG 2 Effect of phospholipids on the in vitro RdRp activity of the p92-167N
RdRp protein. (A) PAGE analysis of the 32P-labeled RNA products obtained in
an in vitro assay with purified p92-167N RdRp protein in the presence of
purified Ssa1 Hsp70 (13 pmol) and DI-mini ()RNA template. In addition,
samples also contained various phospholipids as shown (70 M). See further
details in Fig. 1. Each experiment was repeated two times. (B) Denaturing
PAGE analysis of the 32P-labeled RNA products obtained in an in vitro assay
with FLAG-affinity-purified CNV replicase in the presence of the buffer,
DMSO, or the shown phospholipids (70 M). The template used was DI-72
(	)RNA, which leads to the production of de novo-initiated full-length (top
band, marked with an arrowhead and quantified) and internally initiated
shorter products. Note that samples contained 0.1% detergent required for the
purification of the replicase preparation.
Hsp70 Activates the TBSV RdRp
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To test if the inhibitory effect of PG is dominant over the pro-
viral activity of PC, we mixed PG with PC in 1:1 ratio in the RdRp
activation assay. This resulted in complete inhibition of the RdRp
activity in vitro (Fig. 3B, lanes 7 and 8 versus 9 and 10). Preincu-
bation of the p92-167N RdRp preparation with PC, followed by
addition of PG (in the same amount as PC) 5 min later, did not
prevent the inhibitory effect of PG on RdRp activation (Fig. 3B,
lanes 5 to 6). Altogether, these data indicate that PG’s inhibitory
effect on the p92-167N RdRp activity is dominant in vitro.
PE and PC facilitate viral RNA binding by the RdRp. One of
the interesting features of the TBSV p92-167N RdRp is the se-
lective binding to the cis-acting RII()-SL (Fig. 1B), which is re-
quired for the activation of the TBSV RdRp in vitro (41). In addi-
tion, RII()-SL serves as an RNA recognition element by p33
(p33RE) required for the selection and recruitment of the viral
()RNA for replication in cells and in cell extract (18, 50).
To test if phospholipids affect the binding of the TBSV p92-
167N RdRp to the viral ()RNA carrying the critical p33RE
sequence, we performed EMSA (18). Compared to the buffer con-
trol, PC and PE stimulated RNA binding by the TBSV RdRp by up
to
3-fold (Fig. 4A, lanes 4 to 7 versus 2 and 3), while PS did not
have an effect (lanes 10 and 11). Similarly, lysoPE had stimulatory
effect, while lysoPC and cholesterol did not (Fig. 4A). On the
contrary, PG completely blocked viral RNA binding by the TBSV
p92-167N RdRp (Fig. 4A, lanes 8 and 9). Inhibitory effects were
also observed for CA and PI4P phospholipids (Fig. 4A). Overall,
these data suggest that various phospholipids have major effects,
which can be either stimulatory or inhibitory, on the ability of the
TBSV p92-167N RdRp to bind to the viral ()RNA template in
vitro.
Since PG was inhibitory on the binding of the viral RNA to the
RdRp, we analyzed if this effect is dominant over the stimulatory
effect of PE. Using PG and PE in various ratios in EMSA, we
observed remarkable inhibition by PG on the RNA binding by the
p92-167N RdRp when applied in a 1:1 ratio with the stimulatory
PE (Fig. 4B, lanes 9 and 10 versus 1 and 2). Thus, PG acts domi-
nantly over the stimulatory effect of PE in inhibition of template
binding by the TBSV p92-167N RdRp.
Since different tombusviruses replicate in different subcellular
membranes, such as peroxisomal for TBSV and mitochondrial for
CIRV (11–15), whose membranes differ in lipid composition, we
tested the effect of various phospholipids on the abilities of TBSV
p92-167N RdRp versus the corresponding CIRV p95-200N
RdRp in vitro. The in vitro activation of CIRV p95-200N RdRp
depends on factors similar to those of TBSV p92-167N RdRp
(41). The EMSA revealed comparable profiles for the stimulatory
effect of PE, PC, and lysoPE and a strong inhibitory effect of PG on
viral RNA binding by these RdRp proteins (Fig. 5). Thus, the roles
of given phospholipids in enhancing the activation of these tom-
busvirus RdRps are rather similar. Accordingly, these viruses alter
the phospholipid content of particular subcellular membranes
where their replication takes place by redistributing PE to the sites
of replication (72).
Phospholipids also affect viral RNA binding by the viral p33
replication protein. Cellular membranes and phospholipids are
required for the assembly of the tombusviral replicase complex in
cells and in vitro (18, 33, 49). The virus-coded p33 replication
protein is the major component of the tombusvirus VRC, and it is
required for VRC assembly, viral ()RNA recruitment, and stim-
ulation of de novo viral RNA synthesis by the RdRp (18, 41, 51–
53). To test if various phospholipids could affect the binding of
p33 to the viral ()RNA, we performed an EMSA. Interestingly,
PE and PC stimulated the ability of p33 to bind to the viral
()RNA (Fig. 6A and B). However, unlike in the case of the TBSV
p92-167N RdRp, PG and CA did not inhibit p33-RNA interac-
tion (Fig. 6A) when p33 was added at high concentrations, while
PG and CA inhibited this activity at a lower concentration of p33
(Fig. 6B). When p33 was present at the highest concentration,
none of the phospholipids had effects on p33-RNA interaction
(Fig. 6A, lanes 3 to 10). Altogether, phospholipids affect the ability
of p33 to bind to the viral ()RNA, with PE and PC having stim-
ulatory effects while PG and CA manifest inhibitory effects.
DISCUSSION
Critical role of co-opted Hsp70 in activation of TBSV RdRp.
Tombusvirus replication leads to the production of dsRNA inter-
mediates that are used to make an excess amount of new ()RNA
progeny in infected cells (29). However, dsRNA is a strong inducer
of RNA silencing, an innate antiviral response of the host cells
(8–10). To avoid the rapid induction of the RNA silencing re-
sponse, tombusviruses, similar to other ()RNA viruses, are as-
sumed to hide their dsRNA intermediates in spherule-like mem-
brane structures, which likely make the dsRNA inaccessible to the
RNA silencing machinery (26, 30). Therefore, it is critical for tom-
busviruses to produce an inactive RdRp protein during transla-
FIG 3 Dominant inhibitory effect of PG on the in vitro RdRp activity of the
p92-167N RdRp protein. (A) PAGE analysis of the 32P-labeled RNA products
obtained in an in vitro assay with purified p92-167N RdRp protein in the
presence of purified Ssa1 Hsp70 (13 pmol) and DI-mini ()RNA template. In
addition, samples also contained PG (0.6, 3, or 14 M) or PC (14 M) as
shown. See further details in Fig. 1. Each experiment was repeated two times.
(B) PAGE analysis of the 32P-labeled RNA products obtained in an in vitro
assay with purified p92-167N RdRp protein. Note that PG and PC were used
in a 1:1 ratio, but either PG or PC was added first to the assay (preincubation
with PG and PC in lanes 3 and 4 and lanes 5 and 6, respectively), followed by
addition of the other phospholipid as shown. The samples in a dotted box had
PG and PC added at the same time (lanes 7 and 8). See further details in panel
A.
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tion occurring in the cytosol, followed by RdRp activation only
during VRC assembly in membranous structures. Accordingly,
similar to the yeast- or plant-expressed p92pol (when expressed in
the absence of p33 and the viral RNA), the in vitro-translated
p92pol is inactive as an RdRp protein, albeit it can bind to the viral
RNA (36, 54).
However, the viral RdRp must be activated to support robust
and efficient viral RNA synthesis in the membranous structures.
In this article, we show evidence that the activation of the TBSV
p92-167N requires the co-opted cellular Hsp70 protein, called
Ssa1p in yeast. Ssa1p and the homologous Ssa2p are recruited
from the cytosol to the tombusvirus replicase via binding to p33
and p92, and these Hsp70s are permanent members of the VRC
(19, 30), making them well suited to perform the RdRp activation
function. Also, Ssa1p and Ssa2p were identified in our affinity-
purified p92-167N RdRp preparation (Table 1), suggesting that
FIG 4 Effect of phospholipids on the in vitro RNA-binding activity of the p92-167N RdRp protein. (A) EMSA analysis of the in vitro binding of purified TBSV
p92-167N RdRp to 32P-labeled DI-mini ()RNA [carrying the RII()-SL sequence] (
0.1 pmol). The assay contained the shown phospholipids added in
comparable amounts (70 M). The free or the RdRp-bound ssRNA was separated on nondenaturing 5% Tris-acetate-EDTA (TAE) acrylamide gels. Each
experiment was repeated at least two times. (B) Effect of various ratios of PE to PG on the in vitro RNA-binding activity of the p92-167N RdRp protein. (B)
EMSA analysis of the in vitrobinding of purified p92-167N RdRp to 32P-labeled RNA in the presence of mixed phospholipids. The assay contained various ratios
of PE and PG in comparable amounts of total phospholipids (70 M). See further details in panel A.
FIG 5 Comparable effects of phospholipids on the in vitro RNA-binding activities of the CIRV p95-200N and the TBSV p92-167N RdRp proteins. EMSA
analysis of the in vitro binding of purified CIRV p95-200N RdRp or TBSV p92-167N RdRp to 32P-labeled DI-mini ()RNA template (
0.1 pmol). The assay
contained the shown phospholipids added in comparable amounts (70 M). The free or the RdRp-bound ssRNA was separated on nondenaturing 5%
acrylamide gels. Each experiment was repeated at least two times.
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the viral RdRp and Hsp70 form a complex in yeast. The binding of
Hsp70 likely leads to refolding of the originally inactive RdRp
protein, rendering it competent for RNA synthesis. The newly
discovered RdRp activation function of Hsp70 adds to the list of
tombusviral functions already known to require Hsp70, such as (i)
the intracellular transport/localization of the TBSV replication
proteins (16, 17), (ii) the insertion of the p33 into membranes
(17), and (iii) the assembly of the tombusviral VRC (18).
Although the viral RdRp activation takes place in solution in
our experimental system with the truncated p92-167N RdRp, we
have previously shown that the activation of the full-length p92
RdRp protein also requires the presence of cellular membranes (the
ER membrane in the CFE assay) and the p33 replication protein in
addition to cellular protein factors (11, 41). Similar to the full-length
p92, the truncated p92-167N RdRp is also capable of de novo RNA
synthesis that leads to full-length cRNA on the DI-72 ()RNA tem-
plate in the presence of p33 replication protein and subcellular mem-
branes (41). The difference in the activation mechanisms between the
p92-167N RdRp and the full-length RdRp is due to the N-terminal
portion of the protein, which inhibits RdRp activity until its associa-
tion with the membrane takes place (41). Nevertheless, the require-
ments of the Ssa1p Hsp70 chaperone are likely the same for the p92-
167N RdRp and the full-length RdRp protein.
Interestingly, the activation of reverse transcriptase for hepad-
naviruses depends on Hsp90 proteins (55–57), suggesting that
viruses usurp the heat shock protein apparatus to activate viral
polymerases. The Hsp70 chaperone family and cochaperones
might also be involved in replication of Dengue virus, Hepatitis C
virus, Red clover necrotic mosaic virus, Sindbis virus, BMV, ToMV,
Turnip mosaic virus, Rabies virus, and Borna disease virus (2, 58–
67). Hsp70 functions by an ATP hydrolysis-driven conforma-
tional change that regulates its substrate binding and release. In
addition to being essential for replication of many viruses (1, 2),
members of the cytosolic Hsp70 family are involved in many cel-
lular processes, such as the refolding of misfolded or aggregated
proteins, the folding of newly synthesized proteins, translocation
of organellar and secretory proteins across membranes, insertion
of membrane proteins into the membranes, protein complex as-
sembly and disassembly, protein degradation, and receptor sig-
naling (68, 69).
The roles of phospholipids in binding of replicationproteins
to ()RNA and RdRp activation. The tombusvirus p33 and p92
replication proteins have to switch from the cytosolic to membra-
nous environment during VRC assembly. How can this dramatic
change in the microenvironment affect the biochemical features
of these proteins? Here we show that phospholipids, which are the
main components of intracellular membranes, affect the activa-
tion of the TBSV RdRp and the abilities of the p33 and p92 RdRp
proteins to bind to the viral ()RNA template in vitro. Namely,
the neutral phospholipids PE and PC, which are the most abundant
phospholipids in subcellular membranes, stimulate both activation
of the TBSV RdRp and p33-RNA and p92 RdRp-RNA interactions.
These effects could be important during tombusvirus replication.
This is because PE has been shown to become enriched by p33 at the
sites of tombusvirus replication (72). Thus, the viral RdRp becomes
activated only when it is present in the suitable PE-rich microenvi-
ronment that likely facilitates VRC assembly. The stimulatory effect
of PE and PC on p92-RNA interaction should also favor their mutual
recruitment to the site of viral replication.
In contrast, the inhibitory effect of PG or CA on p92-RNA
interaction and RdRp activation might serve the purpose of pre-
venting tombusvirus RNA synthesis from taking place in a less
FIG 6 Effects of phospholipids on the in vitro RNA-binding activity of the TBSV p33C replication protein. (A) EMSA analysis of the in vitro binding of purified
TBSV p33C (p33 carrying the soluble C-terminal half) to 32P-labeled wild-type RII()-SL template (
0.1 pmol). The assay contained the shown phospholipids
added in comparable amounts (70M). The free or the RdRp-bound ssRNA was separated on nondenaturing 5% acrylamide gels. Each experiment was repeated
at least two times. (B) Similar EMSA analysis as in panel A, except the p33C was preincubated with the shown phospholipids (70M each) for 5 min prior to the
addition of the 32P-labeled RII()-SL RNA probe.
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suitable microenvironment or if mistargeted into the wrong sub-
cellular location. The inhibitory effect of PG on p92-RNA inter-
action is likely the reason that PG can strongly inhibit the activa-
tion of the TBSV RdRp, which requires the p33RE cis-acting
sequence [consisting of the RII()-SL hairpin structure] to be-
come activated (41). Altogether, the complex effects of various
phospholipids on different biochemical activities of the TBSV rep-
lication proteins seem to serve the need of the virus to replicate
only in a favorable microenvironment that is likely well suited for
efficient VRC assembly and spherule formation. The favorable
microenvironment might help tombusviruses to hide from recog-
nition by the host surveillance system and from destruction by the
host innate immunity responses.
These findings might also open up new antiviral approaches
based on manipulation of the concentration of inhibitory versus
stimulatory phospholipids in host cells. Upregulation of PG seems
an especially good target due to the dominant inhibitory effect of
PG on TBSV RdRp activation. These possibilities will need to be
further tested in in vitro replication assays and in cells.
Phospholipids have also been shown to stimulate nodavirus RdRp
(protein A) binding to the viral RNA and protein A self-interactions
(70, 71). Thus, it is likely that the functions of RdRps of other
()RNA viruses are also regulated by cellular phospholipids.
Amodel of the regulatory roles of phospholipids in tombus-
virus replication. The different roles of various phospholipids in
tombusvirus RdRp activation (i.e., stimulatory roles for PE and
PC and dominant inhibitory function for PG) might be utilized by
tombusviruses to regulate new VRC assembly during the course of
infection (Fig. 7). We propose that the tombusvirus RdRp “mea-
sures” the phospholipid homeostasis in infected cells, including
the amount of available PE and PC that could be hijacked for viral
replication. If enough PE and/or PC is available, then the RdRp
could become activated, followed by viral RNA synthesis in the
newly assembled spherules. In contrast, if the free/available PE
and PC levels are sequestered and not available in the suitable
organellar membranes—peroxisomes, endoplasmic reticulum
(ER), or mitochondria—in the infected cells, then binding of the
tombusvirus RdRp to PG could inhibit RdRp activation. This
would block the assembly of the functional VRCs or viral RNA
synthesis when the intracellular conditions are no longer optimal
for viral replication. Altogether, our model predicts that tombus-
viruses might be able to sense the status of the phospholipid ho-
meostasis in infected cells in real time via the availability of various
phospholipids in the preferred subcellular membranes.
It is important to note here, however, that tombusviruses not
only can take advantage of phospholipids present at the beginning
of viral infections, but they actually induce de novo phospholipid
synthesis to render the cells more suitable to support robust tom-
busviral replication (49). Altogether, tombusviruses likely “make
decisions” to assemble or not to assemble new functional VRCs by
sensing the phospholipid composition or content of given subcel-
lular membranes. Future experiments will address how tombus-
viruses rewire the host cell pathways to make membranous mi-
croenvironments more favorable for robust viral replication.
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